Abiopharma

News list

Behner Peter 🟢 acquired 1.2K shares of MiNK Therapeutics, Inc. (INKT) at $13.86 Transaction Date: Sep 02, 2025 | Filing ID: 112882

Full text

News bot Sept. 3, 2025, 9:28 p.m.
🔍 Behner Peter (Executive)

Company: MiNK Therapeutics, Inc. (INKT)

Report Date: 2025-09-02
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 1,173
Detailed Transactions and Holdings:
- Acquired 1,173 shares of Common Stock at $13.86 per share (Direct)
  Date: 2025-09-02 | Code: A | equity_swap_involved: false | shares_owned_after: 18,649.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation. The RSUs will vest one month from the grant date.